Racial Disparities in Primary Therapy for Newly Diagnosed Psoriasis Patients

July 2023 | Volume 22 | Issue 7 | 715 | Copyright © July 2023


Published online June 15, 2023

Rhiannon C. Miller BAa, Mytrang H. Do MD PhDa, Shari R. Lipner MD PhDa

aWeill Cornell Medicine, Department of Dermatology, New York, NY
bWeill Cornell Medicine, Information Technologies & Services Department, New York, NY

Overall, in regard to initial treatment, phototherapy usage for psoriasis has decreased across races, and compared to other races, phototherapy/systemics are prescribed more often to Black patients as initial treatment. Further research is needed to elucidate these differences to provide equitable and effective psoriasis treatments for all patients.

DISCLOSURES

Rhiannon Miller, Dr Mytrang Do, Sajjad Abedian declare that they have no conflicts of interest. Dr Lipner has served as a consultant for Ortho-Dermatologics, Verrica, Hoth Therapeutics, Hexima, and BelleTorus Corporation. IRB: Approved, Protocol #1901019900

REFERENCES

  1. Bell MA, Whang KA, Thomas J, et al. Racial and ethnic disparities in access to emerging and frontline therapies in common dermatological conditions: a cross-sectional study. J Natl Med Assoc. 2020;112(6):650-653. doi: 10.1016/j. jnma.2020.06.009. PMID: 32641259.
  2. Hodges WT, Bhat T, Raval NS, et al. Biologics utilization for psoriasis is lower in black compared with white patients. Br J Dermatol. 2021. doi: 10.1111/ bjd.19876. PMID: 33567102.
  3. Takeshita J, Eriksen WT, Raziano VT, et al. Racial differences in perceptions of psoriasis therapies: implications for racial disparities in psoriasis treatment. J Invest Dermatol. 2019;139(8):1672-1679.e1. doi: 10.1016/j.jid.2018.12.032. PMID: 30738054; PMCID: PMC6650313.
  4. Bray JK, Cline A, McMichael AJ, et al. Differences in healthcare barriers based on racial and/or ethnic background for patients with psoriasis. J Dermatolog Treat. 2019:1-5. doi: 10.1080/09546634.2019.1687824. PMID: 31689125.
  5. Do MH, Schwartz Z, Abedian S, et al. Trends in psoriasis treatment 2005 to 2018: Declining phototherapy utilization and concomitant increased use of biologics. Dermatol Ther. 2020;33(6):e14276. doi: 10.1111/dth.14276. PMID: 32885889.
  6. Dermatol Ther. 2020;33(6):e14276. doi: 10.1111/dth.14276. PMID: 32885889.

AUTHOR CORRESPONDENCE

Shari R. Lipner MD PhD shl9032@med.cornell.edu
Close Menu